A plain-language guide

hypophosphatasia

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Early map · 9 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. hypophosphatasia is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's hypophosphatasia?

Hypophosphatasia is a rare inherited condition in which bone does not mineralise properly, leading to abnormalities of the skeleton and complications elsewhere in the body.

Also indexed asORPHA:436, MONDO:0018570
Features mapped6
Treatments mapped1
Published sources5
Last reviewed2026-08-04

Signs and symptoms

Hypercalcemia

In severe infantile hypophosphatasia, calcium can build up to high levels in the blood, known as hypercalcemia.

Limited evidenceSource: PMID:42170448
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:436
Notesplain_language confirmed from PMID:42170448 via curation 2026-07-27 [Carrie Schluter, BCPA]. | regrounded primary ORPHA:436 -> PMID:42170448 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27

Seizure

Seizures that respond to vitamin B6 have been described in an infant with this condition, alongside poor growth before and after birth, breathing failure, feeding difficulty, poorly mineralised bone, high blood calcium, and a very low alkaline phosphatase level.

Limited evidenceSource: PMID:42170448
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:436
Notesplain_language confirmed from PMID:42170448 via curation 2026-07-27 [llm:opus-5]. | regrounded primary ORPHA:436 -> PMID:42170448 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27

Short stature

Childhood hypophosphatasia varies a good deal from person to person. It can involve bone changes resembling rickets, low bone density, short stature, muscle weakness, early fusion of the skull bones, and losing baby teeth ahead of time.

Limited evidenceSource: PMID:37362163
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:436
Notesplain_language confirmed from PMID:37362163 via curation 2026-07-27 [llm:opus-5]. | regrounded primary ORPHA:436 -> PMID:37362163 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27

Abnormality of the dentition

In adults with hypophosphatasia, severity shows in the bones through fractures that recur or heal poorly, pseudo-fractures and softened bone. It also shows in the teeth, and in day-to-day function such as gait, pain, and needing mobility aids or changes at home.

Limited evidenceSource: PMID:38236379
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:436
Notesplain_language confirmed from PMID:38236379 via curation 2026-07-27 [llm:opus-5]. | regrounded primary ORPHA:436 -> PMID:38236379 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27

Craniosynostosis

In childhood hypophosphatasia, the bones of the skull can fuse together too early, a problem called craniosynostosis.

Limited evidenceSource: PMID:37362163
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:436
Notesplain_language confirmed from PMID:37362163 via curation 2026-07-27 [Carrie Schluter, BCPA]. | regrounded primary ORPHA:436 -> PMID:37362163 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27

Recurrent fractures

In adults, hypophosphatasia often shows as fractures that keep recurring or heal poorly.

Limited evidenceSource: PMID:38236379
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:436
Notesplain_language confirmed from PMID:38236379 via curation 2026-07-27 [Carrie Schluter, BCPA]. | regrounded primary ORPHA:436 -> PMID:38236379 on 2026-07-27 [Carrie Schluter, BCPA]
Last reviewed2026-07-27

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

asfotase alfa

Asfotase alfa improves bone health, mobility, growth, and breathing, and relieves pain.

Used to help with: Hypophosphatasia.

Limited evidenceSource: PMID:40110697
The source text this rests on
“Asfotase alfa improves bone health, mobility, growth, and breathing ability, and relieves pain.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:40110697 via curation 2026-07-27
Last reviewed2026-07-27

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 5 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

PMID:37362163 · A unique case of childhood hypophosphatasia caused by a novel heterozygous 51-bp in-frame deletion in the ALPL gene.
PMID:38236379 · A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States.
PMID:39089608 · Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review.
PMID:40110697 · Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies.
PMID:42170448 · Infantile hypophosphatasia caused by compound heterozygous variants in the ALPL gene: a case report.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.